We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

92 hedge funds and large institutions have $276M invested in Tango Therapeutics in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

12% more funds holding

Funds holding: 82 → 92 (+10)

1.22% more ownership

Funds ownership: 77.96% → 79.18% (+1.2%)

9% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 23

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

45% less capital invested

Capital invested by funds: $498M → $276M (-$223M)

Holders
92
Holders Change
+10
Holders Change %
+12.2%
% of All Funds
1.47%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
18
Increased
25
Reduced
23
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$5.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.47M
3
TCM
Tang Capital Management
California
+$1.16M
4
Millennium Management
Millennium Management
New York
+$981K
5
Squarepoint
Squarepoint
New York
+$538K

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$2.1M
2
FCM
Farallon Capital Management
California
-$1.96M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.12M
4
Invesco
Invesco
Georgia
-$1.1M
5
OMC
Oasis Management Company
Cayman Islands
-$848K
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
76
STRS Ohio
Ohio
$43K – – –
SG
77
StoneX Group
New York
$42.9K +$63K +10,859 New
JAFL
78
Jay A. Fishman Ltd
Michigan
$39.5K – – –
Wells Fargo
79
Wells Fargo
California
$32.7K +$48K +8,268 New
Citigroup
80
Citigroup
New York
$32.4K -$12.5K -2,152 -21%
Point72 Asset Management
81
Point72 Asset Management
Connecticut
$29K +$42.6K +7,346 New
AB
82
Amalgamated Bank
New York
$19K -$6.27K -1,081 -18%
PMEF
83
Point72 Middle East FZE
United Arab Emirates
$14.2K +$20.8K +3,583 New
Zurich Cantonal Bank
84
Zurich Cantonal Bank
Switzerland
$13.9K +$20.4K +3,507 New
AIP
85
Ameritas Investment Partners
Nebraska
$13.8K – – –
Lazard Asset Management
86
Lazard Asset Management
New York
$12K +$3.92K +676 +26%
Royal Bank of Canada
87
Royal Bank of Canada
Ontario, Canada
$10K -$23.4K -4,037 -61%
MLICM
88
Metropolitan Life Insurance Company (MetLife)
New York
$9.81K -$4.77K -822 -25%
CUAMC
89
China Universal Asset Management Company
China
$4.72K +$1.74K +299 +33%
MWM
90
Mascoma Wealth Management
New Hampshire
$3.4K +$5.8K +1,000 New
Federated Hermes
91
Federated Hermes
Pennsylvania
$1.63K +$2.39K +412 New
Daiwa Securities Group
92
Daiwa Securities Group
Japan
$1K – – –
Walleye Capital
93
Walleye Capital
New York
– -$2.1M -289,867 Closed
FCM
94
Farallon Capital Management
California
– -$1.96M -270,000 Closed
OMC
95
Oasis Management Company
Cayman Islands
– -$848K -117,000 Closed
D.E. Shaw & Co
96
D.E. Shaw & Co
New York
– -$220K -30,404 Closed
Allspring Global Investments
97
Allspring Global Investments
North Carolina
– -$208K -28,730 Closed
Walleye Trading
98
Walleye Trading
New York
– -$112K -15,381 Closed
Nisa Investment Advisors
99
Nisa Investment Advisors
Missouri
– -$104K -14,290 Closed
QL
100
Quarry LP
New York
– -$1.93K -266 Closed
1 2 3
4

TNGX Hedge Fund Activity: Q1 2023 in Review

92 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q1 2023, worth a combined $276M — down 45% from $498M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TNGX positions and 8 closed out — a net gain of 10 holders — while 25 added to existing stakes and 23 trimmed.

The largest buyer was Casdin Capital, opening a new position worth an estimated $5.8M. The largest seller was Walleye Capital, exiting entirely with an estimated $2.1M sold.

  • 92 institutional investors held Tango Therapeutics (TNGX) as of Q1 2023, up from 82 in Q4 2022.
  • Funds reported $276M of Tango Therapeutics stock for Q1 2023, down 45% quarter-over-quarter.
  • 18 funds opened new Tango Therapeutics positions in Q1 2023 and 8 closed out, a net change of +10 holders.
  • The largest Tango Therapeutics buyer in Q1 2023 was Casdin Capital, an estimated $5.8M added.
  • The largest Tango Therapeutics seller in Q1 2023 was Walleye Capital, an estimated $2.1M sold.

Based on aggregated 13F filings for Q1 2023.